Feb 16, 2017 02:02 PM IST | Source:

Buy Max India; target of Rs 175: Edelweiss

Edelweiss is bullish on Max India has recommended buy rating on the stock with a target price of Rs 175 in its research report dated February 14, 2017.

  • bselive
  • nselive
Todays L/H

Edelweiss' research report on Max India

MHC, Max India’s (Max) hospitals business revenue/EBITDA grew 14%/ 17% YoY, despite headwinds from demonetisation and weaker onset of winter compared to last year. Core operating metrics remained robust with ARPOB growing 7% YoY, and occupancy steady at 69%. Gross premiums in healthcare insurance business increased 24% and Max maintained EBITDA breakeven guidance for FY19 in this business.


We believe Max is a compelling bet on the tertiary care opportunity in the NCR market, which could have upsides from investments in health insurance. Maintain ’BUY’ with TP of INR 175.

For all recommendations, click here

The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.
Follow us on
Available On